Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial

D. Day; A. Starus; A. Lamik; O. Sieber; S. Begbie; A. Bonaventura; S. Rai; N. Karanth; C. R. Underhill; L. M. Nott; G. Van Hazel; T. Van Hagen; M. Wong; A. Saqib; M. Eastgate; R. Srivastav; J. Chia; H. C. Toh; F. Jones; E. Segelov

doi:10.1016/j.annonc.2022.07.518

Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial

D. Day, A. Starus, A. Lamik, O. Sieber, S. Begbie, A. Bonaventura, S. Rai, N. Karanth, C. R. Underhill, L. M. Nott, G. Van Hazel, T. Van Hagen, M. Wong, A. Saqib, M. Eastgate, R. Srivastav, J. Chia, H. C. Toh, F. Jones, E. Segelov

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S710-S710
Number of pages	1
Journal	Annals of Oncology
Volume	33
Issue number	7
DOIs	https://doi.org/10.1016/j.annonc.2022.07.518
Publication status	Published - Sept 2022
Event	2022 Annual Meeting of the European-Society-for-Medical-Oncology - , France Duration: 9 Sept 2022 → 13 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2022.07.518

Cite this

Day, D., Starus, A., Lamik, A., Sieber, O., Begbie, S., Bonaventura, A., Rai, S., Karanth, N., Underhill, C. R., Nott, L. M., Van Hazel, G., Van Hagen, T., Wong, M., Saqib, A., Eastgate, M., Srivastav, R., Chia, J., Toh, H. C., Jones, F., & Segelov, E. (2022). Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial. Annals of Oncology, 33(7), S710-S710. https://doi.org/10.1016/j.annonc.2022.07.518

@article{a089db154c04491dbdfe8bbf84616fcb,

title = "Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial",

author = "D. Day and A. Starus and A. Lamik and O. Sieber and S. Begbie and A. Bonaventura and S. Rai and N. Karanth and Underhill, \{C. R.\} and Nott, \{L. M.\} and \{Van Hazel\}, G. and \{Van Hagen\}, T. and M. Wong and A. Saqib and M. Eastgate and R. Srivastav and J. Chia and Toh, \{H. C.\} and F. Jones and E. Segelov",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.518",

language = "English",

volume = "33",

pages = "S710--S710",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "7",

note = "2022 Annual Meeting of the European-Society-for-Medical-Oncology, ESMO 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

}

Day, D, Starus, A, Lamik, A, Sieber, O, Begbie, S, Bonaventura, A, Rai, S, Karanth, N, Underhill, CR, Nott, LM, Van Hazel, G, Van Hagen, T, Wong, M, Saqib, A, Eastgate, M, Srivastav, R, Chia, J, Toh, HC, Jones, F & Segelov, E 2022, 'Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial', Annals of Oncology, vol. 33, no. 7, pp. S710-S710. https://doi.org/10.1016/j.annonc.2022.07.518

TY - JOUR

T1 - Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial

AU - Day, D.

AU - Starus, A.

AU - Lamik, A.

AU - Sieber, O.

AU - Begbie, S.

AU - Bonaventura, A.

AU - Rai, S.

AU - Karanth, N.

AU - Underhill, C. R.

AU - Nott, L. M.

AU - Van Hazel, G.

AU - Van Hagen, T.

AU - Wong, M.

AU - Saqib, A.

AU - Eastgate, M.

AU - Srivastav, R.

AU - Chia, J.

AU - Toh, H. C.

AU - Jones, F.

AU - Segelov, E.

PY - 2022/9

Y1 - 2022/9

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000866211600374

U2 - 10.1016/j.annonc.2022.07.518

DO - 10.1016/j.annonc.2022.07.518

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 33

SP - S710-S710

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

T2 - 2022 Annual Meeting of the European-Society-for-Medical-Oncology

Y2 - 9 September 2022 through 13 September 2022

ER -

Tumour naive circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial

UN SDGs

Access to Document

Other files and links

Cite this